Samsung Bioepis said it has commenced global phase 3 clinical trials for its biosimilar, SB27, a biosimilar referencing Keytruda, a blockbuster cancer treatment developed by MSD.SB27 marks the company's eleventh biosimilar pipeline, illustrating its ongoing commitment to expanding its portfolio in t
Eylea Injection 8 mg (aflibercept), which sharply increased the dose from the existing Eylea Injection 2 mg,, has won approval in Korea, drawing attention to whether it will be able to defend its leading position in the retinal disease market from Roche's Vabysmo (faricimab) and Eylea biosimilars.On
After undergoing surgery, chemotherapy, or radiation, many cancer patients adhere strictly to their doctors' advice to abstain from alcohol. However, once their treatment concludes, some may question whether it's acceptable to resume drinking. Is this truly advisable?"In the past, there existed the
The Fair Trade Commission (FTC) is reportedly looking into Novo Nordisk Korea over allegations of monopolistic practices related to the cessation of its needle supply, NovoFine Plus pen needle.On Thursday, Joongang Ilbo, a Korean daily newspaper, first reported that the FTC's Seoul office dispatched
GC Cell, a contract development and manufacturing organization (CDMO) for cell and gene therapies, said Thursday that it has ushered in Kang Jin-hee, a clinical development and global regulatory expert, as its chief development officer to strengthen its R&D capabilities.According to GC Cell, the new
"To eliminate hepatitis C, countries must test a wider range of people for the disease. Even low-income countries like Rwanda in Africa are testing all adults for hepatitis C. We have heard that Korea is also considering including Hepatitis C testing in its national screening program. It is importan
Crystal Life Sciences said it changed its name to Huons Life Sciences and will continue its operations under the new name.The name changing decision was made at a recent extraordinary shareholders’ meeting.As a subsidiary of Huons, Huons Life Sciences will reorganize its portfolio in line with the v
One of the biggest issues in Korea these days is the conflict between the government and doctors over increasing the number of medical school students. Hit hardest in this process are cancer patients. When people are diagnosed with cancer, they become impatient and want to get treatment as soon as p
Boryung (formerly Boryung Pharmaceutical), a strong player in the domestic anticancer drug market, draws the industry’s attention by tying up with Bixink Therapeutics, which holds the domestic rights to Nerlynx Tablets (neratinib maleate), a new drug for HER2-positive breast cancer.Bixink Therapeuti
The Ministry of Health and Welfare, in collaboration with the Korea Health Industry Development Institute and Novo Nordisk, hosted the "Novo Nordisk Partnering Day- Korea 2024" on Thursday.The two-day event, part of a broader open innovation initiative, aims to foster collaboration between startups
Following his public speech on Monday, President Yoon Suk Yeol has proposed a direct dialogue with striking interns and residents. However, trainee doctors remain skeptical, worrying that the meeting would be a place of persuasion and appeasement instead of dialogue.A presidential spokesperson said
Seoul National University Bundang Hospital (SNUBH) said it has embarked on a mentorship to reform Colombia’s healthcare system comprehensively and strengthen its role as a future medical cooperation partner.The announcement follows the hospital staff recently visiting Colombia after the Colombia’s M
In a moving display of unity and dedication, the Korea Blood Disease & Cancer Association (KBDCA) and the Korean Multiple Myeloma Working Party (KMMWP), under the Korean Society of Hematology, concluded a ceremony to celebrate the 9th World Myeloma Awareness Month.KBDCA is a non-profit organization
There's a myth that coffee should not be drunk because it can dehydrate your body and increase your risk of constipation. Is this true, however? The answer is no."People, who don't know much, think that if you are constipated for a long time, you might get colon cancer," said Professor Cha Jae-myung
VUNO, a Korean medical AI company, said Wednesday that it had completed the U.S. trademark registration of VUNO Med-DeepCARS, an artificial intelligence-based cardiac arrest prediction device.VUNO Med-DeepCARS is the first AI medical device in the Korean medical AI industry to be designated as an in
As part of the emergency medical care system to cope with doctors' collective action, the government will expand non-face-to-face medical treatment implemented by all types of medical institutions to public health centers and their branch offices.The government said so at Wednesday's regular briefin
Astellas Pharma Korea said it hosted the Satellite Symposium during the 2024 International Congress of the Korean Society of Hematology (ICKSH 2024) held at the Grand Walker Hill Seoul from March 28 to 30 to share the latest advances in the treatment of acute myeloid leukemia (AML).Professor Naoko H
In a troubling trend for the biotechnology sector in Korea, several companies are on the brink of delisting from the tech-heavy Kosdaq due to failing to secure necessary audit approvals amidst a harsh investment climate and lackluster sales and research outcomes.According to reports from the Korea E
Hahn & Co., a Korean private equity investment company, has completed the acquisition of Cynosure, a U.S. medical aesthetics company specializing in laser and light-based treatments, and is now taking steps to integrate Cynosure with Lutronic, a developer of advanced medical and aesthetic lasers and
To increase the options for hospice and life-sustaining treatment users, the government pushes to expand the target diseases and the timing to suspend end-of-life care that has been limited to patients’ dying days.The Ministry of Health and Welfare said Tuesday that it has finalized the "Second Comp